Previous Article | Next Article 
Infection and Immunity, December 2002, p. 7042-7049, Vol. 70, No. 12
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.12.7042-7049.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Effect of Trimethoprim-Sulfamethoxazole on Recurrent Bacteriuria and Bacterial Persistence in Mice Infected with Uropathogenic Escherichia coli
Joel D. Schilling,1 Robin G. Lorenz,2,3,
and Scott J. Hultgren1*
Department of Molecular Microbiology,1
Department of Pathology and Immunology,2
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 631103
Received 24 April 2002/
Returned for modification 20 June 2002/
Accepted 28 August 2002
One of the more perplexing aspects of urinary tract infections (UTIs) is their high propensity to recur. It has been proposed that recurrent infections are a result of the reintroduction of bacteria from the gastrointestinal tract (GIT) to the urinary tract (UT); however, since a significant subset of recurrent UTIs are caused by an identical bacterial strain, it has been challenging to formally prove this hypothesis for same-strain recurrences by using epidemiologic approaches. We present data here obtained by using a mouse model of UTIs in which it was shown that 36% (5 of 14) of mice infected with uropathogenic Escherichia coli (UPEC) will have at least one bacteriuric recurrence, with 21% (3 of 14) having more than one recurrence during a 6-week period after an acute UTI. Intraurethrally infected mice develop UPEC reservoirs in both their feces and their bladders. Ten days of trimethoprim-sulfamethoxazole (SXT) therapy reduces urinary recurrences and eradicates fecal colonization, whereas 3 days of SXT treatment has no effect over a twenty-eight-day observation period despite clearing fecal colonization acutely. Interestingly, SXT is unable to eradicate bacteria from the bladder reservoir even after a 10-day treatment regimen, thus demonstrating that the bladder reservoir can persist even in the face of long-term antibiotic therapy.
* Corresponding author. Mailing address: Department of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Phone: (314) 362-7059. Fax: (314) 362-3203. E-mail:
hultgren{at}borcim.wustl.edu.
Editor: A. D. O'Brien
Present address: Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294.
Infection and Immunity, December 2002, p. 7042-7049, Vol. 70, No. 12
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.12.7042-7049.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Dhakal, B. K., Mulvey, M. A.
(2009). Uropathogenic Escherichia coli Invades Host Cells via an HDAC6-modulated Microtubule-dependent Pathway. J. Biol. Chem.
284: 446-454
[Abstract]
[Full Text]
-
Rosen, D. A., Pinkner, J. S., Jones, J. M., Walker, J. N., Clegg, S., Hultgren, S. J.
(2008). Utilization of an Intracellular Bacterial Community Pathway in Klebsiella pneumoniae Urinary Tract Infection and the Effects of FimK on Type 1 Pilus Expression. Infect. Immun.
76: 3337-3345
[Abstract]
[Full Text]
-
Garofalo, C. K., Hooton, T. M., Martin, S. M., Stamm, W. E., Palermo, J. J., Gordon, J. I., Hultgren, S. J.
(2007). Escherichia coli from Urine of Female Patients with Urinary Tract Infections Is Competent for Intracellular Bacterial Community Formation. Infect. Immun.
75: 52-60
[Abstract]
[Full Text]
-
Justice, S. S., Hunstad, D. A., Seed, P. C., Hultgren, S. J.
(2006). Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl. Acad. Sci. USA
103: 19884-19889
[Abstract]
[Full Text]
-
Casaz, P., Garrity-Ryan, L. K., McKenney, D., Jackson, C., Levy, S. B., Tanaka, S. K., Alekshun, M. N.
(2006). MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology
152: 3643-3650
[Abstract]
[Full Text]
-
Mysorekar, I. U., Hultgren, S. J.
(2006). Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. USA
103: 14170-14175
[Abstract]
[Full Text]
-
Ejrnaes, K., Sandvang, D., Lundgren, B., Ferry, S., Holm, S., Monsen, T., Lundholm, R., Frimodt-Moller, N.
(2006). Pulsed-Field Gel Electrophoresis Typing of Escherichia coli Strains from Samples Collected before and after Pivmecillinam or Placebo Treatment of Uncomplicated Community-Acquired Urinary Tract Infection in Women.. J. Clin. Microbiol.
44: 1776-1781
[Abstract]
[Full Text]
-
Kerrn, M. B., Struve, C., Blom, J., Frimodt-Moller, N., Krogfelt, K. A.
(2005). Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother
55: 383-386
[Abstract]
[Full Text]
-
Duncan, M. J., Li, G., Shin, J.-S., Carson, J. L., Abraham, S. N.
(2004). Bacterial Penetration of Bladder Epithelium through Lipid Rafts. J. Biol. Chem.
279: 18944-18951
[Abstract]
[Full Text]
-
Justice, S. S., Hung, C., Theriot, J. A., Fletcher, D. A., Anderson, G. G., Footer, M. J., Hultgren, S. J.
(2004). From the Cover: Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA
101: 1333-1338
[Abstract]
[Full Text]
-
Anderson, M., Bollinger, D., Hagler, A., Hartwell, H., Rivers, B., Ward, K., Steck, T. R.
(2004). Viable but Nonculturable Bacteria Are Present in Mouse and Human Urine Specimens. J. Clin. Microbiol.
42: 753-758
[Abstract]
[Full Text]
-
Anderson, G. G., Palermo, J. J., Schilling, J. D., Roth, R., Heuser, J., Hultgren, S. J.
(2003). Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections. Science
301: 105-107
[Abstract]
[Full Text]